Bandingkan Harga & Kinerja Indomobil Sukses Internasional Tbk. (IMAS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indomobil Sukses Internasional Tbk. dan Organon Pharma Indonesia Tbk.: Indomobil Sukses Internasional Tbk. diperdagangkan di Rp900 (kapitalisasi pasar 3,67 T, volume 24 jam 258 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indomobil Sukses Internasional Tbk. jauh lebih besar — sekitar 35,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IMAS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,67 T | 104,4 M |
Volume | 258 rb | — |
Lot | 2,58 rb | — |
Perputaran | 231,83 jt | — |
Harga Rata-rata | 898,55 | — |
Nilai Transaksi | 231,83 jt | — |
Harga Ekuilibrium Indikatif | 900 | — |
Volume Ekuilibrium Indikatif | 236 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indomobil Sukses Internasional Tbk.
PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.
Selengkapnya di halaman IMAS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
